About
Technology
Issues
FAQ
Links
Official Page
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.